1. Khalil A, Majlath M, Gounant V, Hess A, Laissy JP, Debray MP. Contribution of magnetic resonance imaging in lung cancer imaging. Diagn Interv Imaging. 2016; 97:991–1002.
Article
2. Hochhegger B, Marchiori E, Sedlaczek O, et al. MRI in lung cancer: a pictorial essay. Br J Radiol. 2011; 84:661–668.
Article
3. Koyama H, Ohno Y, Seki S, et al. Magnetic resonance imaging for lung cancer. J Thorac Imaging. 2013; 28:138–150.
Article
4. Kim HS, Lee KS, Ohno Y, van Beek EJ, Biederer J. PET/CT versus MRI for diagnosis, staging, and follow-up of lung cancer. J Magn Reson Imaging. 2015; 42:247–260.
Article
5. Gaeta M, Ascenti G, Mazziotti S, Contiguglia R, Barone M, Mileto A. MRI differentiation of pneumonia-like mucinous adenocarcinoma and infectious pneumonia. Eur J Radiol. 2012; 81:3587–3591.
Article
6. Gaeta M, Minutoli F, Ascenti G, et al. MR white lung sign: incidence and significance in pulmonary consolidations. J Comput Assist Tomogr. 2001; 25:890–896.
Article
7. Liu Y, Zhang HL, Mei JZ, et al. Primary mucinous adenocarcinoma of the lung: a case report and review of the literature. Oncol Lett. 2017; 14:3701–3704.
Article
8. Guimaraes MD, Marchiori E, Odisio BC, et al. Functional imaging with diffusion-weighted MRI for lung biopsy planning: initial experience. World J Surg Oncol. 2014; 12:203.
Article
9. Natsume M, Sano H, Fukusada S, et al. Gadolinium as an alternative radiocontrast agent in patients with allergy to iodine-based contrast provide for useful diagnostic imagings and safely treatment of biliary tract diseases. Nihon Shokakibyo Gakkai Zasshi. 2013; 110:825–832.
10. Fraioli F, Screaton NJ, Janes SM, et al. Non-small-cell lung cancer resectability: diagnostic value of PET/MR. Eur J Nucl Med Mol Imaging. 2015; 42:49–55.
Article